Scientists trace radioactive drug through healthy volunteers
NCT ID NCT07454863
Summary
This is a very early, first-in-human study to understand how a potential new drug for non-Hodgkin lymphoma is processed by the body. Six healthy adult male volunteers will take a single, small oral dose containing a tiny, safe amount of radioactive tracer. Researchers will closely measure how the drug is absorbed, broken down, and eliminated through urine and feces over several days.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LYMPHOMA, NON-HODGKIN are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Affiliated Hospital of Jiangnan University
Wuxi, Jiangsu, 214062, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.